Li YX. Clinical curative effect observation of Shufeng Jiedu capsule on wind-heat cold. Clin J Tradit Chin Med. 2015;27(05):674–5.

Google Scholar 

Hu R, Wang LH, Zhang JJ, et al. Clinical observation of Shufeng Jiedu Capsule for treating acute pharyngitis. Drug Eval Res. 2014;37(05):460–2.

Google Scholar 

Ren H, Jiang Y, Wang S, et al. Efficacy and safety of Shufeng Jiedu Capsule in the treatment of acute exacerbations of chronic obstructive pulmonary disease: a protocol for systematic review and meta-analysis. Medicine. 2021;100(1): e24198.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hu XY, Oliver T, Willcox M, et al. Treating acute exacerbations of COPD with Chinese herbal medicine to aid antibiotic use reduction (EXCALIBUR): study protocol of a randomised double-blind, placebo-controlled feasibility trial. Pilot Feasibility Stud. 2022;8(1):262.

Article  PubMed  PubMed Central  Google Scholar 

Zhang XW, Xia RY, Gao JQ, et al. Chinese patent medicine Shufeng Jiedu Capsules as an adjuvant therapy for community-acquired pneumonia: a systematic review and meta-Analysis of randomized clinical trials. Front Pharmacol. 2022;13: 923395.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ji S, Bai Q, Wu X, et al. Unique synergistic antiviral effects of Shufeng Jiedu Capsule and oseltamivir in influenza A viral-induced acute exacerbation of chronic obstructive pulmonary disease. Biomed Pharmacother. 2020;121: 109652.

Article  CAS  PubMed  Google Scholar 

Chen J, Lin S, Niu C, et al. Clinical evaluation of Shufeng Jiedu Capsules combined with umifenovir (Arbidol) in the treatment of common-type COVID-19: a retrospective study. Expert Rev Respir Med. 2021;15(2):257–65.

Article  CAS  PubMed  Google Scholar 

Zhang B, Pei W, Cai P, et al. Recent advances in Chinese patent medicines entering the international market. Drug Discov Ther. 2022;16(6):258–72.

Article  PubMed  Google Scholar 

Guo MN, Liu SX, Zhao YM, et al. Analysis on chemical constituents in Bupleuri Radix by HPLC-Q-TOF-MS. Chin Tradit Herbal Drugs. 2016;47(12):2044–52.

Google Scholar 

Zhang CX, Liu SX, Zhao YM, et al. Analysis on chemical constituents from Forsythiae Fructus by HPLC-Q-TOF-MS. Chin Tradit Herbal Drugs. 2016;47(12):2053–60.

Google Scholar 

Zhao YM, Liu SX, Zhang CX, et al. Analysis on chemical constituents from Glycyrrhizae Radix et Rhizoma by HPLC-Q-TOF-M. Chin Tradit Herbal Drugs. 2016;47(12):2027–33.

Google Scholar 

Zhang TJ, Zhu YX, Liu SX, et al. Promotion on systematic quality standard of Shufeng Jiedu Capsule. Chin Tradit Herbal Drugs. 2016;47(12):2061–8.

Google Scholar 

Zhang TJ, Zhu YX, Liu DL, et al. Study on pharmacodynamic material basis and mechanism of Shufeng Jiedu Capsule. Chin Tradit Herbal Drugs. 2016;47(12):2019–26.

Google Scholar 

Zhang TJ, Zhu YX, Liu DL, et al. Systematic research of secondary development of Shufeng Jiedu Capsule. Chin Tradit Herbal Drugs. 2019;50(15):3517–25.

Google Scholar 

Li Y, Chang N, Han Y, et al. Anti-inflammatory effects of Shufengjiedu capsule for upper respiratory infection via the ERK pathway. Biomed Pharmacother. 2017;94:758–66.

Article  PubMed  Google Scholar 

Liu X, Zhang H, Xu J, et al. Identification of absorbed components and their metabolites in rat plasma after oral administration of Shufeng Jiedu capsule using ultra-performance liquid chromatography/quadrupole time-of-flight mass spectrometry. Rapid Commun Mass Spectrom. 2019;33(19):1494–501.

Article  CAS  PubMed  Google Scholar 

Tao Z, Meng X, Han YQ, et al. Therapeutic Mechanistic Studies of ShuFengJieDu Capsule in an acute lung injury animal model using quantitative proteomics technology. J Proteome Res. 2017;16(11):4009–19.

Article  CAS  PubMed  Google Scholar 

Tao Z, Chen J, Su J, et al. Quantitative Proteomics analysis of systemic responses and biological mechanisms of ShuFengJieDu Capsule Using H1N1-Infected RAW264.7 Cells. ACS Omega. 2020;5(25):15417–23.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Han YQ, Cao Y, Dong YN, et al. Spectrum-effect relationship of anti-inflammatory activity of Shufeng Jiedu Capsule based on neural network analysis. Chin Tradit Herbal Drugs. 2019;50(15):3526–33.

Google Scholar 

Han YQ, Cao Y, Dong YN, et al. Spectrum-effect relationship of wind-dispersing and exterior syndrome-relieving of Shufeng Jiedu Capsules. Chinese Tradit Herbal Drugs. 2019;50(15):3534–40.

Google Scholar 

Bao Y, Gao Y, Cui X. Efect of Shufeng Jiedu capsules as a broad-spectrum antibacterial. Biosci Trends. 2016;10:74–8.

Article  CAS  PubMed  Google Scholar 

Lv WW, Zhu TN, Qiu H, et al. Pharmacodynamic study on antiviral and antibacterial effects of Shufeng Jiedu capsules in vitro. Tradit Chin Drug Res Clin Pharmacol. 2013;24(3):234–8.

Google Scholar 

Bao YY, Gao YJ, Shi YJ, et al. Study on Broad-spectrum antiviral effect of Shufeng Jiedu Capsules. J New Chin Med. 2019;51(12):5–8.

Google Scholar 

Liu Y, Cui XL, Shi H, et al. Study on pharmacodynamic trial in Vivo of Shufengjiedu capsule on prevention and treatment of influenza. World J Integr Tradit Western Med. 2010;5(01):35–9.

Google Scholar 

Liu Y, Shi H, Jin YH, et al. Experimental pharmacodynamic research in Vivo of Shufengjiedu capsule on treatment and prevention of influenza. World J Integ Tradit Western Med. 2010;5(02):107–10.

Google Scholar 

Li ZH, Zhang H, Chen JL, et al. Shufeng-Jiedu capsule protects against pneumonia induced by influenza A virus H1N1 via miR-155/JAK1-STAT1 signaling pathway in mice. Chin J Pathophysiol. 2022;38(7):1219–25.

Google Scholar 

Qiu H, Li ZC, Zhu TN, et al. In-vivo experimental research of antiviral action of Shufeng Jiedu Capsule. Tradit Chin Drug Res Clin Pharmacol. 2014;25(1):14–7.

CAS  Google Scholar 

Xia L, Shi Y, Su J, et al. Shufeng Jiedu, a promising herbal therapy for moderate COVID-19: antiviral and anti-inflammatory properties, pathways of bioactive compounds, and a clinical real-world pragmatic study. Phytomedicine. 2021;85: 153390.

Article  CAS  PubMed  Google Scholar 

Simayi J, Nuermaimaiti M, Wumaier A, et al. Analysis of the active components and mechanism of Shufeng Jiedu capsule against COVID-19 based on network pharmacology and molecular docking. Medicine. 2022;101(1): e28286.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Xiong H, Dong Z, Lou G, et al. Analysis of the mechanism of Shufeng Jiedu capsule prevention and treatment for COVID-19 by network pharmacology tools. Eur J Integr Med. 2020;40: 101241.

Article  PubMed  PubMed Central  Google Scholar 

Chen X, Yin YH, Zhang MY, et al. Investigating the mechanism of ShuFeng JieDu capsule for the treatment of novel Coronavirus pneumonia (COVID-19) based on network pharmacology. Int J Med Sci. 2020;17(16):2511–30.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhuang Z, Zhong X, Zhang H, et al. Exploring the Potential Mechanism of Shufeng Jiedu Capsule for Treating COVID-19 by comprehensive network pharmacological approaches and molecular docking validation. Comb Chem High Throughput Screen. 2021;24(9):1377–94.

Article  CAS  PubMed  Google Scholar 

Tao Z, Zhang L, Friedemann T, et al. Systematic analyses on the potential immune and anti-inflammatory mechanisms of Shufeng Jiedu Capsule against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)-caused pneumonia. J Funct Foods. 2020;75: 104243.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Tao Z, Gao J, Zhang G, et al. Shufeng Jiedu Capsule protect against acute lung injury by suppressing the MAPK/NF-κB pathway. Biosci Trends. 2014;8(1):45–51.

Article  PubMed  Google Scholar 

Tao ZG, Gao JY, Xue MM, et al. Shufeng Jiedu Capsule regulates LPS-induced acute lung injury via inhibiting MAPK/NF-κB pathways. China J Tradit Chin Med Pharm. 2014;29(3):911–5.

CAS  Google Scholar 

Yuan Y, Liao Q, Xue M, et al. Shufeng Jiedu Capsules alleviate lipopolysaccharide-induced acute lung inflammatory injury via activation of GPR18 by verbenalin. Cell Physiol Biochem. 2018;50(2):629–39.

Article  CAS  PubMed  Google Scholar 

Cai J, Wang YL, Sheng XD, et al. Shufeng Jiedu capsule inhibits inflammation and apoptosis by activating A2AAR and inhibiting NF-κB to alleviate LPS-induced ALI. J Ethnopharmacol. 2022;298: 115661.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Liao Q, Chen W, Tong Z, et al. Shufeng Jiedu capsules protect rats against LPS-induced acute lung injury via activating NRF2-associated antioxidant pathway. Histol Histopathol. 2021;36(3):317–24.

CAS  PubMed  Google Scholar 

Mei J, Kong H, Zhao Z, et al. Shufengjiedu capsules protect against neuronal loss in olfactory epithelium and lung injury by enhancing autophagy in rats with allergic rhinitis. Biosci Trends. 2020;13(6):530–8.

Article  PubMed  Google Scholar 

He ZL, Fang WJ, Zhang FB, et al. Effect of intestinal absorption liquid containing breeze detoxification capsule on lps-induced cytokines reaction in macrophage. Modern Chin Med. 2015;17(4):345–8.

Google Scholar 

Ma L, Huang Y, Hou YB, et al. Anti-inflammatory mechanism of Shufeng Jiedu Capsules in rat pneumonia model. Chin Tradit Herbal Drugs. 2018;49(19):4591–5.

Google Scholar 

Shi J, Luo Y. Effect of Shufeng Jiedu capsule on the repair mechanism and immunologic function of COPD mouse pulmonary oxidative damage. Prog Anatomical Sci. 2021;27(5):561–4.

Google Scholar 

Wu FH, Song RJ, Cai CY, et al. Effect of Shufeng Jiedu Capsules on serum T cell subsets CD3+, CD4+ /CD8+ in rats with acute pharyngitis. Beijing J Tradit Chin Med. 2020;39(7):689–92.

Google Scholar 

Han YQ, Dong YN, Xu J, et al. Study on mechanism of anti-inflammation and immunoregulation of Shufeng Jiedu Capsule based on network pharmacology. Chin Tradit Herbal Drugs. 2019;50(15):3555–62.

Google Scholar 

Wang ZY, Ge L, Meng ZJ, et al. Pharmacodynamics and pharmacoeconomic analysis of the antipyretic effects of Chaiqinqingning capsule, Qingkailing capsule, Qingrejiedu capsule, Shufengjiedu capsule. Chin J Clin Rat Drug Use. 2019;12(11A):3–6.

Google Scholar 

Liu J, Ma L, Lu J, et al. Study on mechanism for antipyretic effects of Shufeng Jiedu Capsule. Chin Tradit Herbal Drugs. 2016;47(12):2040–3.